SYBR Green | GenomeWeb

SYBR Green

Bio-Rad this week launched the SsoAdvanced Universal Inhibitor-Tolerant SYBR Green Supermix.

In Cambodia's Ratanakiri Province, main roads project like spokes from the small city of Banlung, population 17,000. Here, next to the local health department, a team of Cambodian and Belgian researchers intent on eliminating malaria parked a mobile PCR lab last fall.

A team of scientists from Japan's Riken and DNAForm has developed a highly efficient fluorescent molecular probe for combined real-time PCR monitoring and melting curve analysis, according to research published this week in

Clinical researchers from the Stanford University School of Medicine have published a study demonstrating how their laboratory-developed multiplex real-time PCR-based assay to detect Shiga toxin-producing E.

Sigma Life Science, a division of Sigma Aldrich, is attempting to increase its share of the qPCR market by introducing for the first time pre-designed qPCR products to complement the custom product design work that has comprised the core of its business for the past several years

The arrangement is the latest in a spate of intellectual property licensing agreements that Idaho Technology has made with various biotechnology companies in relation to the SYBR Green technology over the last several years.

The deal covers use of SYBR Green in PCR reactions and-high resolution melting.

Idaho Tech recently completed licensing agreements with DuPont Qualicon and two undisclosed life science companies — the latest in a spate of similar deals that take advantage of Idaho Tech's "broad and valuable intellectual property portfolio" in cooperation with Roche Diagnostics.

The company already offers many of these services to customers in North America and Europe through Gaithersburg, Md.-based subsidiary Gene Logic.

Pages

In Science this week: metagenomic-based technique for determining protein structure, and more.

An academic laments the rise of narcissism in the sciences, the Guardian reports.

Outgoing FDA commissioner Robert Califf writes in an editorial that the agency can help boost innovation.

The Trump transition team has asked NIH Director Francis Collins to remain at his post, though it's unclear for how long that will be.